Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,065 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $858.09 | 14 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $113.39 | 5 | $0 (2024) |
| Lundbeck LLC | $93.07 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $236.25 | 10 | Takeda Pharmaceuticals U.S.A., Inc. ($113.39) |
| 2023 | $482.48 | 10 | ABBVIE INC. ($458.94) |
| 2022 | $215.82 | 2 | ABBVIE INC. ($215.82) |
| 2021 | $130.00 | 1 | AbbVie Inc. ($130.00) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.15 | General |
| Category: PSYCHIATRY | ||||||
| 06/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.62 | General |
| Category: PSYCHIATRY | ||||||
| 01/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.76 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.54 | General |
| Category: PSYCHIATRY | ||||||
| 11/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.22 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $122.73 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $97.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $118.82 | General |
| Category: NEUROSCIENCE | ||||||
| 08/18/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $130.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 34 | 245 | $26,070 | $10,842 |
| 2022 | 2 | 38 | 265 | $26,480 | $12,480 |
| 2021 | 2 | 32 | 237 | $23,505 | $11,411 |
| 2020 | 2 | 28 | 150 | $14,445 | $6,848 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 17 | 123 | $10,360 | $6,006 | 58.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 122 | $15,710 | $4,836 | 30.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 19 | 133 | $10,640 | $6,924 | 65.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 19 | 132 | $15,840 | $5,556 | 35.1% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 16 | 120 | $9,465 | $6,370 | 67.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 16 | 117 | $14,040 | $5,041 | 35.9% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 14 | 79 | $5,925 | $4,341 | 73.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 14 | 71 | $8,520 | $2,507 | 29.4% |
About Nnachi Mba, NP
Nnachi Mba, NP is a Psychiatric/Mental Health healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2019. The National Provider Identifier (NPI) number assigned to this provider is 1649838996.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nnachi Mba, NP has received a total of $1,065 in payments from pharmaceutical and medical device companies, with $236.25 received in 2024. These payments were reported across 23 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($1,065).
As a Medicare-enrolled provider, Mba has provided services to 132 Medicare beneficiaries, totaling 897 services with total Medicare billing of $41,582. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Bronx, NY
- Active Since 06/02/2019
- Last Updated 06/02/2019
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1649838996
Products in Payments
- VRAYLAR (Drug) $858.09
- TRINTELLIX (Drug) $113.39
- REXULTI (Drug) $93.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Bronx
Chia-Wei Lin, Rn, RN
Psychiatric/Mental Health — Payments: $10,978
Steve Velazquez
Psychiatric/Mental Health — Payments: $3,189
Mary Olson, Np, NP
Psychiatric/Mental Health — Payments: $2,929
Mrs. Rosario Fernandez, Nurse Practitioner, NURSE PRACTITIONER
Psychiatric/Mental Health — Payments: $2,002
Shalita Clark, Crnp, CRNP
Psychiatric/Mental Health — Payments: $1,792
Esther Lebovic, Fnp, Pmhnp, FNP, PMHNP
Psychiatric/Mental Health — Payments: $1,685